Low-temperature
photothermal therapy (PTT) is a noninvasive method
that harnesses the photothermal effect at low temperatures to selectively
eliminate tumor cells, while safeguarding normal tissues, minimizing
thermal damage, and enhancing treatment safety. First we evaluated
the transcriptome of tumor cells at the gene level following low-temperature
treatment and observed significant enrichment of genes involved in
cell cycle and heat response-related signaling pathways. To address
this challenge, we have developed an engineering multifunctional nanoplatform
that offered an all-in-one strategy for efficient sensitization of
low-temperature PTT. Specifically, we utilized MoS2 nanoparticles
as the photothermal core to generate low temperature (40–48
°C). The nanoplatform was coated with DPA to load CPT-11 and
Fe2+ and was further modified with PEG and iRGD to enhance
tumor specificity (MoS2/Fe@CPT-11-PEG-iRGD). Laser- and
acid-triggered release of CPT-11 can significantly increase intracellular
H2O2 content, cooperate with Fe2+ ions to increase intracellular lipid ROS content, and activate ferroptosis.
Furthermore,
CPT-11 induced cell cycle arrest in the temperature-sensitive S-phase,
and increased lipid ROS levels contributed to the degradation of HSPs
protein expression. This synergistic approach could effectively induce
tumor cell death by the sensitized low-temperature PTT and the combination
of ferroptosis and chemotherapy. Our nanoplatform can also maximize
tumor cell eradication and prolong the survival time of tumor-bearing
mice in vivo. The multifunctional approach will provide more possibilities
for clinical applications of low-temperature PTT and potential avenues
for the development of multiple tumor treatments.